Alasdair P. Macgowan
Bristol, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 153 publications
Reconciling differences between EUCAST 'breakpoint-defining doses' and UK national antimicrobial treatment guidelines.
Journal: The Journal of antimicrobial chemotherapy
Published: September 08, 2026
Multisite clinical evaluation of the iFAST rapid antimicrobial susceptibility test direct from positive blood cultures containing gram-negative organisms.
Journal: Journal of clinical microbiology
Published: August 31, 2026
Defining a target product profile for antimicrobials to treat severe paediatric bacterial enteric infections in low- and medium-income countries, caused by E. coli, Shigella, Salmonella and Campylobacter species.
Journal: JAC-antimicrobial resistance
Published: July 11, 2026
MexXY-OprM efflux pump mediates resistance to odilorhabdins in Pseudomonas aeruginosa.
Journal: Microbiology spectrum
Published: June 16, 2026
Meropenem and fosfomycin against Klebsiella pneumoniae: author's response.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: May 22, 2026
Cefalexin use in UK acute pyelonephritis practice: unaddressed challenges in dosing, breakpoints and clinical evidence.
Journal: The Journal of antimicrobial chemotherapy
Published: February 26, 2026
Importance of reviewing the package insert from gradient strip manufacturers.
Journal: The Journal of antimicrobial chemotherapy
Published: December 12, 2025
Meropenem and fosfomycin against Klebsiella pneumoniae: Towards a combination breakpoint using a pharmacometric approach.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: November 26, 2025
Rifampicin as monotherapy for infections caused by Staphylococcus aureus: considerations for not applying 'breakpoints in brackets'.
Journal: The Journal of antimicrobial chemotherapy
Published: November 03, 2025
Applications and benefits of the British Society for Antimicrobial Chemotherapy Resistance Surveillance Project-legacy and future.
Journal: The Journal of antimicrobial chemotherapy
Published: October 27, 2025
Two decades of resistance surveillance by the British Society for Antimicrobial Chemotherapy: design, development, delivery, deficiencies and future directions.
Journal: The Journal of antimicrobial chemotherapy
Published: October 27, 2025
The magnitude of the pharmacodynamic index for NOSO-502: pathogen clearance, emergence of resistance and human dose predictions.
Journal: The Journal of antimicrobial chemotherapy
Published: October 06, 2025
Last Updated: 09/26/2026